Publication Year

Connor K, Harris M, Edwards M, Chu A, Clark G, Finley B. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study. Dioxin 2004, Berlin, Germany, 2004.

Proctor DM, Panko JP, Liebig EW, Paustenbach, DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg. 1(11):752–767; doi: 10.1080/15459620490523294.

Haws, L. Roundtable: Is it time to reevaluate the toxic equivalency factors for PCDDs, PCDFs, and dioxin-like PCBs? The use of toxicity equivalence factors (TEFs) for PCDDs, PCDFs, and dioxin-like PCBs in risk assessment: Improving the process. Dioxin 2004. September Berlin, Germany, September 2004.

Schecter, A, Papke O, Tung KC, Staskal DF, Birnbaum L. 2004. Polybrominated diphenyl ether contamination of United States food. Environ Sci Technol 38(20):5306-5311; doi: 10.1021/es0490830.

Haws L, Harris M, Su S, Birnbaum L, DeVito M, Farland W, Walker N, Connor K, Santamaria A, Finley B. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004, Berlin, Germany, 2004.

Haws L, Harris M, Su S, Walker N, Birnbaum L, DeVito M, Farland W, Connor K, Santamaria A, Finley B. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004, Berlin, Germany, 2004.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; PMID: 14600248.

Perry CS, Morton E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis Annual Meeting, Palm Springs, CA, December 2004.

Warren DA, Kerger BD, Britt JK, James RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40(1):42-53; doi: 10.1016/j.yrtph.2004.04.005.

Panko JM, Unice KM, Shay EC, Price P. Childhood exposure assessment of acetone. International Society for Exposure Assessment, 2004.

Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67:43–71.

Proctor DM, Panko JM, Liebig EW, Paustenbach DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. J Occup Environ Hyg 1(11):752–767; doi: 10.1080/15459620490523294.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Tissue distribution and elimination of BDE 47 in mice following a single oral dose. Dioxin 2004, Berlin, Germany, September 2004.

Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, et al. 2004. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem Toxicol 42(4):559–569; doi: 10.1016/j.fct.2003.10.015. PMID: 15019179.

Alexander W, Berlin J, Cyr PL, Schofield A, Platt LA. 2004. Realities at the leading edge of research. EMBO Rep 5(4):324-329; doi: 10.1038/sj.embor.7400137.

Chepanoske CL, Brown K, Turteltaub KW, Dingley KH. 2004. Characterization of a peptide adduct formed by N-acetoxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a reactive intermediate of the food carcinogen PhIP. Food Chem Toxicol 42(8):1367–1372; doi: 10.1016/j.fct.2003.11.012. PMID: 15207388.

Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H., et al. 2004. Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17(2):234–242; doi: 10.1021/tx034188m. PMID: 14967011.

Rogers JM, Brannen KC, Barbee BD, Zucker RM, Degitz SJ. 2004. Maternal methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis and cervical vertebral malformations in C57BL/6J mice. Birth Defects Res B 71(2):80-88; doi: 10.1002/bdrb.20003.

Degitz SJ, Rogers JM, Zucker RM, Hunter ES III. 2004. Developmental toxicity of methanol: Pathogenesis in CD-1 and C57BL/6J mice exposed in whole embryo culture. Birth Defects Res A 70(4):179–184; doi: 10.1002/bdra.20009.

Degitz SJ, Zucker RM, Kawanishi CY, Massenburg GS, Rogers JM. 2004. Pathogenesis of methanol-induced craniofacial defects in C57BL/6J mice. Birth Defects Res A 70(4):172–178; doi: 10.1002/bdra.20010.